• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SYSTEM RED 72 REPERFUSION CATHETER; NRY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SYSTEM RED 72 REPERFUSION CATHETER; NRY Back to Search Results
Catalog Number RED72
Device Problems Fracture (1260); Stretched (1601); Physical Resistance/Sticking (4012)
Patient Problems Foreign Body In Patient (2687); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/22/2024
Event Type  malfunction  
Manufacturer Narrative
This device is available for return.A follow up mdr will be submitted upon completion of the device investigation.
 
Event Description
The patient was undergoing a thrombectomy procedure in the common carotid artery (cca) using a penumbra system red 72 reperfusion catheter (red72), a non-penumbra balloon guide catheter, and a non-penumbra short introducer sheath.During the procedure, the physician placed the balloon guide catheter using the short introducer sheath below the bifurcation of the cca via femoral access.A contrast run was then performed, and the physician advanced the red72 towards the thrombus for the first pass without a guidewire or an intermediate catheter.It was reported that the red72 bent over at the distal length and the physician retracted the red72 to straighten it.The physician moved the balloon guide catheter upwards then inflated the balloon.While retracting the red72 through the balloon guide catheter under aspiration, the physician experienced resistance.Upon removal of the red72, the physician noticed that the distal segment was stretched and fractured.It was observed under fluoroscopy that the red72 distal fragment was located parallel to the balloon guide catheter in the opposite direction.The physician then used a 50cc syringe to manually aspirate slowly with caution the distal fragment of the red72 into the balloon guide catheter and then removed the guide catheter from the short introducer sheath.The procedure was completed using a penumbra system red 62 reperfusion catheter (red62) and a non-penumbra long introducer sheath via femoral puncture on the contralateral side.
 
Manufacturer Narrative
Please note that the following sections were incorrectly reported on the initial mfr report and are being corrected on this follow-up #01 mfr report: 3005168196-2024-00122.Evaluation of the returned red72 confirmed that the catheter was fractured.Stretching was present near the fractured location.If the red72 was retracted against resistance, damage such as stretching and subsequent fracture may occur.If a guidewire is not utilized during advancement of the red72, the catheter shaft may kink and contribute to resistance during use.Further evaluation revealed kinks along the catheter shaft.This damage was incidental to the reported complaint and may have occurred during packaging of the device for return to penumbra.Penumbra catheters are inspected during in-process inspection and during quality inspection after manufacturing.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.
 
Event Description
The patient was undergoing a thrombectomy procedure in the common carotid artery (cca) using a penumbra system red 72 reperfusion catheter (red72), a non-penumbra balloon guide catheter, and a non-penumbra short introducer sheath.During the procedure, the physician placed the balloon guide catheter using the short introducer sheath below the bifurcation of the cca via femoral access.A contrast run was then performed, and the physician advanced the red72 towards the thrombus for the first pass without a guidewire or an intermediate catheter.It was reported that the red72 prolapsed at the distal length and the physician retracted the red72 to straighten it.The physician moved the balloon guide catheter upwards then inflated the balloon.While retracting the red72 through the balloon guide catheter under aspiration, the physician experienced resistance.Upon removal of the red72, the physician noticed that the distal segment was stretched and fractured.It was observed under fluoroscopy that the red72 marker was located proximal to the balloon guide catheter distal tip outside of the guide catheter.The physician then used a 50cc syringe to manually aspirate the distal fragment of the red72 into the balloon guide catheter and then the guide catheter was removed.The procedure was completed using a penumbra system red 62 reperfusion catheter (red62) and a non-penumbra long introducer sheath via femoral puncture on the contralateral side.There was no report of an adverse effect to the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SYSTEM RED 72 REPERFUSION CATHETER
Type of Device
NRY
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key19038298
MDR Text Key339325959
Report Number3005168196-2024-00122
Device Sequence Number1
Product Code NRY
UDI-Device Identifier00815948023925
UDI-Public815948023925
Combination Product (y/n)N
Reporter Country CodeSW
PMA/PMN Number
K211654
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/01/2005,05/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberRED72
Device Lot NumberH00003739
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Initial Date Manufacturer Received 03/05/2024
Initial Date FDA Received04/03/2024
Supplement Dates Manufacturer Received04/12/2024
Supplement Dates FDA Received05/13/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/03/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-